ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

30,257Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 3647

$1.33M Total Retail Price of All Prescriptions

Rank: 108 out of 3647

874 Patients Receiving at Least One Drug in Part D
88%Patients 65 Years and Older
69% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

5% of this provider’s 874 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

4% of this provider’s 26,842 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
OMEPRAZOLE 1,461 1,296 1 3
SIMVASTATIN 1,226 1,085 2 1
AMLODIPINE BESYLATE 1,134 989 3 2
LISINOPRIL 823 669 4 4
RANITIDINE HCL 800 655 5 29
CLOPIDOGREL 615 523 6 26
LEVOTHYROXINE SODIUM 602 502 7 5
IBUPROFEN 565 459 8 55
MEGESTROL ACETATE 513 469 R 10 9 138
PLAVIX 482 433 10 39
METOPROLOL TARTRATE 477 418 11 7
FUROSEMIDE 471 455 12 8
METFORMIN HCL 439 397 13 6
DIGOXIN 439 411 13 51
ATENOLOL 417 402 15 10
FAMOTIDINE 402 345 16 61
ALENDRONATE SODIUM 391 388 17 23
POTASSIUM CHLORIDE 385 363 18 24
ALPRAZOLAM 381 359 19 31
SUCRALFATE 373 326 20 219
DONEPEZIL HCL 358 342 21 30
CARVEDILOL 357 321 22 20
CRESTOR 354 321 23 19
TAMSULOSIN HCL 339 318 24 28
LACTULOSE 319 280 25 128
PAROXETINE HCL 311 295 26 60
LOSARTAN POTASSIUM 291 291 27 11
MELOXICAM 291 248 27 33
NAMENDA 285 285 29 49
ALBUTEROL SULFATE 273 198 30 157
SILVER SULFADIAZINE 268 257 31 243
GABAPENTIN 263 230 32 17
ISOSORBIDE MONONITRATE ER 253 234 33 56
GLYBURIDE 247 209 R 34 54
ZOLPIDEM TARTRATE 244 232 35 14
INSULIN SYRINGE 235 204 36 76
METOCLOPRAMIDE HCL 231 212 37 135
CARBIDOPA-LEVODOPA 218 195 38 127
DOXAZOSIN MESYLATE 217 207 39 57
NEXIUM 210 210 40 44
TEMAZEPAM 207 200 41 47
PANTOPRAZOLE SODIUM 193 184 42 38
NAPROXEN 182 146 43 70
GEMFIBROZIL 181 97 44 82
MUPIROCIN 180 145 45 137
ZAFIRLUKAST 175 129 10 46 366
HYDRALAZINE HCL 164 129 47 81
AMLODIPINE BESYLATE-BENAZEPRIL 161 150 48 74
LANTUS 160 139 49 59
PHENYTOIN SODIUM EXTENDED 159 140 50 199
ENALAPRIL MALEATE 159 127 50 35
OXYBUTYNIN CHLORIDE 151 133 52 107
METOPROLOL SUCCINATE 147 144 53 18
NOVOLOG MIX 70-30 140 92 54 261
DIOVAN 140 137 54 40
AVODART 138 138 56 173
KETOCONAZOLE 136 94 57 132
PREDNISONE 136 111 57 43
DICLOFENAC SODIUM 133 126 59 86
CLONIDINE HCL 131 95 60 46
QUETIAPINE FUMARATE 129 114 61 89
SSD 128 126 62 310
CLONAZEPAM 127 121 63 146
AZITHROMYCIN 124 118 64 34
HYDROCHLOROTHIAZIDE 117 111 65 9
ADVAIR DISKUS 116 82 66 52
MECLIZINE HCL 114 114 67 85
AMMONIUM LACTATE 113 104 68 141
ALLOPURINOL 112 102 69 37
THEOPHYLLINE ANHYDROUS 111 41 70 333
PENTOXIFYLLINE 108 108 71 180
BENZTROPINE MESYLATE 108 61 R 71 222
SINGULAIR 107 90 73 90
NITROGLYCERIN PATCH 106 96 74 203
FLUTICASONE PROPIONATE 106 86 74 32
NIFEDIPINE ER 102 96 76 67
GLIPIZIDE 97 85 77 41
ESCITALOPRAM OXALATE 96 96 78 65
WARFARIN SODIUM 96 87 78 15
INDOMETHACIN 95 67 R 80 355
GLYBURIDE-METFORMIN HCL 93 83 R 81 94
CIPROFLOXACIN HCL 92 84 82 53
LORAZEPAM 92 85 82 73
CITALOPRAM HBR 89 85 84 25
DIOVAN HCT 87 83 85 80
SURE COMFORT 85 69 86 161
ACETAMINOPHEN-CODEINE 81 79 S3 87 149
NOVOLIN 70-30 78 71 88 130
ATORVASTATIN CALCIUM 78 75 88 13
LEVOFLOXACIN 78 74 88 87
NYSTATIN 77 70 91 195
MONTELUKAST SODIUM 76 68 92 160
LANSOPRAZOLE 75 70 93 116
TRAMADOL HCL 73 72 94 22
DEXILANT 72 68 95 207
BENAZEPRIL HCL 72 72 95 71
LABETALOL HCL 71 59 97 172
ACTOS 71 70 97 148
TRAZODONE HCL 70 63 99 64
RISPERIDONE 66 61 100 83
CHOLESTYRAMINE 65 63 101 430
CAPTOPRIL 63 63 102 193
PROAIR HFA 63 62 102 62
DOXYCYCLINE HYCLATE 63 60 102 145
LYRICA 61 51 105 120
FOLIC ACID 61 61 105 95
SERTRALINE HCL 60 60 107 27
GALANTAMINE HBR 58 58 108 245
SYNTHROID 58 58 108 42
LOSARTAN-HYDROCHLOROTHIAZIDE 58 47 108 48
DEXAMETHASONE 58 57 108 467
SPIRIVA 56 37 112 93
VOLTAREN 55 55 113 102
CARBAMAZEPINE 54 26 114 308
CLOTRIMAZOLE-BETAMETHASONE 52 52 115 84
CELEBREX 52 40 115 111
LIDODERM 51 45 117 108
DICYCLOMINE HCL 50 49 118 194
FINASTERIDE 50 41 118 66
SANTYL 50 43 118 233
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 11, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.